Report
Author : United States. Congress. House
Publisher :
Page : 2172 pages
File Size : 40,32 MB
Release :
Category : United States
ISBN :
Author : United States. Congress. House
Publisher :
Page : 2172 pages
File Size : 40,32 MB
Release :
Category : United States
ISBN :
Author : United States. Congress. House
Publisher :
Page : 1314 pages
File Size : 47,8 MB
Release : 1961
Category : Legislation
ISBN :
Some vols. include supplemental journals of "such proceedings of the sessions, as, during the time they were depending, were ordered to be kept secret, and respecting which the injunction of secrecy was afterwards taken off by the order of the House."
Author : Connecticut. Secretary of the State
Publisher :
Page : 764 pages
File Size : 11,40 MB
Release : 1962
Category : Connecticut
ISBN :
Author : Institute of Medicine
Publisher : National Academies Press
Page : 377 pages
File Size : 38,37 MB
Release : 2013-06-20
Category : Medical
ISBN : 0309269393
The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.
Author : Joint United Nations Programme on HIV/AIDS.
Publisher : World Health Organization
Page : 226 pages
File Size : 24,85 MB
Release : 2005
Category : Health & Fitness
ISBN :
This report presents three hypothetical case studies for how the AIDS epidemic in Africa could evolve over the next 20 years based on policy decisions taken today by African leaders and the rest of the world; and considers the factors likely to drive the future responses of African countries and the international community. The scenarios draw on the age-old tradition of story-telling, rather than using data projections, to explore the wider context of the AIDS epidemic, reflecting the complexity of the subject matter.
Author : United States. Congress. Senate. Committee on Agriculture and Forestry
Publisher :
Page : 56 pages
File Size : 33,84 MB
Release : 1955
Category : Fungibles
ISBN :
Author : National Defense University
Publisher : NDU Press
Page : 356 pages
File Size : 20,75 MB
Release : 2010-10
Category : History
ISBN : 1780390408
Despite the vital importance of the emerging area of biotechnology and its role in defense planning and policymaking, no definitive book has been written on the topic for the defense policymaker, the military student, and the private-sector bioscientist interested in the "emerging opportunities market" of national security. This edited volume is intended to help close this gap and provide the necessary backdrop for thinking strategically about biology in defense planning and policymaking. This volume is about applications of the biological sciences, here called "biologically inspired innovations," to the military. Rather than treating biology as a series of threats to be dealt with, such innovations generally approach the biological sciences as a set of opportunities for the military to gain strategic advantage over adversaries. These opportunities range from looking at everything from genes to brains, from enhancing human performance to creating renewable energy, from sensing the environment around us to harnessing its power.
Author :
Publisher :
Page : 900 pages
File Size : 10,84 MB
Release : 1907
Category : Iowa
ISBN :
Author : Felicia Knaul
Publisher :
Page : 0 pages
File Size : 20,45 MB
Release : 2013
Category :
ISBN :
Cancer has become a leading cause of death and disability and a serious yet unforeseen challenge to health systems in low-and middle-income countries. A protracted and polarized cancer transition is under way and fuels a concentration of preventable risk, illness, suffering, impoverishment from ill health, and death among poor populations. Closing this cancer divide is an equity imperative. The world faces a huge, unperceived cost of failure to take action that requires an immediate and large-scale global response. Closing the Cancer Divide presents strategies for innovation in delivery, pricing, procurement, finance, knowledge-building, and leadership that can be scaled up by applying a diagonal approach to health system strengthening. The chapters provide evidence-based recommendations for developing programs, local and global policy-making, and prioritizing research. The cases and frameworks provide a guide for developing responses to the challenge of cancer and other chronic illnesses. The book summarizes results of the Global Task Force on Expanding Access to Cancer Care and Control in Developing Countries, a collaboration among leaders from the global health and cancer care communities worldwide, originally convened by Harvard University. It includes contributions from civil society, global and national policy-makers, patients and practitioners, and academics representing an array of fields.
Author : The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada
Publisher : Council of Canadian Academies
Page : 268 pages
File Size : 17,61 MB
Release : 2019-11-12
Category : Medical
ISBN : 1926522753
When Antibiotics Fail examines the current impacts of AMR on our healthcare system, projects the future impact on Canada’s GDP, and looks at how widespread resistance will influence the day-to-day lives of Canadians. The report examines these issues through a One Health lens, recognizing the interconnected nature of AMR, from healthcare settings to the environment to the agriculture sector. It is the most comprehensive report to date on the economic impact of AMR in Canada.